A new organisation dedicated to increasing the use of digital health in the NHS in Wales has come into being, 18 months after the move was first unveiled by the Welsh government. <
New biotech Antiverse has raised seed funding of £1.4 million ($2 million) to develop its artificial intelligence-based platform for discovering therapeutic antibodies.
Patients in Wales are to gain faster access to medicines recommended by NICE and Wales’ own cost-effectiveness body, the All Wales Medicines Strategy Group (AWMSG).